Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Colon Cancer
Women who have stopped estrogen plus progestin therapy may be at increased risk of cancer
March 20th, 2008
A follow-up study of women who stopped taking the hormone therapy of estrogen plus progestin after this intervention was discontinued as part of a clinical trial indicates that these women may have an increased risk of cancer, compared to women in the placebo group, according to a study in the March 5 issue of JAMA. Cardiovascular disease and fracture risks were similar between the two groups, but women who took hormone therapy had an overall higher global risk index reflecting the balance of risks and benefits from a number of endpoints combined, including deaths. The Women's Health Initiative (WHI) trial of estrogen plus progestin, which included 16,608 postmenopausal...
Source: Women's Health Weekly (2008-03-20)
|
